ADD/ADHD Drug GUide - Part 5

This week, we need to take a look at a non-stimulant drug used to treat ADD/ADHD.  It’s brand name is Atomoxetine, but you may recognize it as Strattera.  Despite its very hefty price tag, it is becoming widely used for adults and children.

Strattera is known as a selective norepinephrenine reuptake inhibitor.  This means that it strengthens the chemical signal between the nerves that use norepinephrine to send messages.  It does not seem to affect the dopamine systems as directly as stimulants drugs do, but it does cause a secondary increase in dopamine levels in the brain area located behind your eyes.   This is the area that is associated with the ability to mentally rehearse responses and inhibit impulsivity.  It’s also associated with your working memory.  It is not thought to be at such a high risk for abuse because it is not a Schedule II drug (known for significant potential for addiction) like the stimulants.

While professionals still prefer to try stimulants first, this drug has a gradual and subtle onset.  It takes a few days to reach a maximum effect, and some report they’ve had to take it for as long as 3 weeks before seeing any effects.  It is taken once or twice a day, and that makes it preferable for children as they don’t have to remember a dose at school.

Please Login or Register to read the rest of this content.

So there you have it - the good, the bad, and the ugly - about taking the non-stimulant Strattera.  I am still of the opinion that if you want to try a “pill” for your ADD/ADHD symptoms, wouldn’t you prefer a more natural route?